December 31, 2014 / 4:03 PM / 3 years ago

BUZZ-Tekmira Pharmaceuticals Corp: Completes patient enrollment

** U.S-listed shares of Canadian drugmaker up 22 pct at $17, Toronto-listed shares up 15 pct at C$18.58

** Company says completes patient enrollment in early-stage study of its cancer drug TKM-PLK1

** Tekmira says it expects final data in mid-2015

** More than 1 mln shares changed hands on Nasdaq by 10.24 am ET; more than 3 times the 10-day moving average; About 148,000 shares traded in Toronto, about average

** Up to Tuesday's close, stock had risen 74 pct this year, largely due to excitement over its potential Ebola drug

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below